As of 2024-07-27, the Relative Valuation of TG Therapeutics Inc (TGTX) is 6.33 USD. This relative valuation is based on P/E multiples. With the latest stock price at 20.57 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -69.2%.
The range of the Relative Valuation is 2.04 - 12.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.8x - 47.7x | 39.8x |
| Forward P/E multiples | 30.1x - 31.2x | 30.6x |
| Fair Price | 2.04 - 12.71 | 6.33 |
| Upside | -90.1% - -38.2% | -69.2% |
| Date | P/E |
| 2024-07-26 | 77.18 |
| 2024-07-25 | 74.99 |
| 2024-07-24 | 73.49 |
| 2024-07-23 | 76.07 |
| 2024-07-22 | 76.71 |
| 2024-07-19 | 78.81 |
| 2024-07-18 | 79.68 |
| 2024-07-17 | 82.87 |
| 2024-07-16 | 84.52 |
| 2024-07-15 | 79.83 |
| 2024-07-12 | 79.53 |
| 2024-07-11 | 80.28 |
| 2024-07-10 | 76.94 |
| 2024-07-09 | 74.72 |
| 2024-07-08 | 73.37 |
| 2024-07-05 | 71.35 |
| 2024-07-03 | 70.52 |
| 2024-07-02 | 68.72 |
| 2024-07-01 | 68.12 |
| 2024-06-28 | 66.77 |
| 2024-06-27 | 67.37 |
| 2024-06-26 | 66.54 |
| 2024-06-25 | 72.02 |
| 2024-06-24 | 69.09 |
| 2024-06-21 | 66.24 |
| 2024-06-20 | 63.73 |
| 2024-06-18 | 62.94 |
| 2024-06-17 | 62.19 |
| 2024-06-14 | 62.11 |
| 2024-06-13 | 62.90 |
| 2024-06-12 | 63.09 |
| 2024-06-11 | 60.61 |
| 2024-06-10 | 59.67 |
| 2024-06-07 | 59.49 |
| 2024-06-06 | 59.34 |
| 2024-06-05 | 62.04 |
| 2024-06-04 | 60.84 |
| 2024-06-03 | 61.29 |
| 2024-05-31 | 61.17 |
| 2024-05-30 | 63.39 |
| 2024-05-29 | 61.40 |
| 2024-05-28 | 63.24 |
| 2024-05-24 | 62.71 |
| 2024-05-23 | 63.73 |
| 2024-05-22 | 66.43 |
| 2024-05-21 | 62.30 |
| 2024-05-20 | 61.85 |
| 2024-05-17 | 61.85 |
| 2024-05-16 | 65.38 |
| 2024-05-15 | 66.50 |